Clinical and Biological Outcomes of BioBrace-Augmented ACL Reconstruction

This prospective, single-center, single-arm observational cohort study aims to evaluate the clinical, radiological, and arthroscopic outcomes and safety of primary anterior cruciate ligament (ACL) reconstruction augmented with the BioBrace® Reinforced BioInductive Implant. A total of 30 patients who decided to undergo BioBrace-augmented ACL reconstruction in routine clinical practice will be followed for up to 24 months postoperatively. Knee stability, graft maturation via MRI and second-look arthroscopy, patient-reported outcomes, and complications will be assessed.